{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:55:56Z","timestamp":1790736956719,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2358,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CS\/13\/2\/30584"],"award-info":[{"award-number":["CS\/13\/2\/30584"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Morphine is shown to relieve chronic breathlessness in chronic obstructive pulmonary disease. There are no definitive data in people with heart failure. We aimed to determine the effectiveness and cost-effectiveness of 12 weeks morphine therapy for the relief of chronic breathlessness in people with chronic heart failure compared with placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Parallel group, double-blind, randomized, placebo-controlled, phase III trial of 20 mg daily oral modified release morphine was conducted in 13 sites in England and Scotland: hospital\/community cardiology or palliative care outpatients. The primary analysis compared between-group numerical rating scale average breathlessness\/24 hours at week 4 using a covariance pattern linear mixed model. Secondary outcomes included treatment-emergent harms (worse or new). The trial closed early due to slow recruitment, randomizing 45 participants [average age 72 (range 39\u201389) years; 84% men; 98% New York Heart Association class III]. For the primary analysis, the adjusted mean difference was 0.26 (95% confidence interval, \u22120.86 to 1.37) in favour of placebo. All other breathlessness measures improved in both groups (week 4 change-from-baseline) but by more in those assigned to morphine. Neither group was excessively drowsy at baseline or week 4. There were no between-group differences in quality of life (Kansas) or cognition (Montreal) at any time point. There was no exercise-related desaturation and no change between baseline and week 4 in either group. There was no change in vital signs at week 4. The natriuretic peptide measures fell in both groups but by more in the morphine group [morphine 2169 (1092, 3851) pg\/mL vs. placebo 2851 (1694, 5437)] pg\/mL. There was no excess serious adverse events in the morphine group. Treatment-emergent harms during the first week were more common in the morphine group; all apart from 1 were \u2264 grade 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We could not answer our primary objectives due to inadequate power. However, we provide novel placebo-controlled medium-term benefit and safety data useful for clinical practice and future trial design. Morphine should only be prescribed in this population when other measures are unhelpful and with early management of side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12498","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T02:44:26Z","timestamp":1565145866000},"page":"1149-1160","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Oral Modified Release Morphine for Breathlessness in Chronic Heart Failure: A Randomized Placebo-Controlled Trial"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6204-9158","authenticated-orcid":false,"given":"Miriam J.","family":"Johnson","sequence":"first","affiliation":[{"name":"Wolfson Palliative Care Research Centre, University of Hull , Hull, HU6 7RX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cockayne","sequence":"additional","affiliation":[{"name":"York Trials Unit, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Currow","sequence":"additional","affiliation":[{"name":"Wolfson Palliative Care Research Centre, University of Hull , Hull, HU6 7RX ,","place":["UK"]},{"name":"IMPACCT, Faculty of Health, University of Technology Sydney , Ultimo, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Bell","sequence":"additional","affiliation":[{"name":"York Trials Unit, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Hicks","sequence":"additional","affiliation":[{"name":"York Trials Unit, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Fairhurst","sequence":"additional","affiliation":[{"name":"York Trials Unit, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian","family":"Gabe","sequence":"additional","affiliation":[{"name":"Hull York Medical School and York Trials Unit, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Torgerson","sequence":"additional","affiliation":[{"name":"York Trials Unit, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Jefferson","sequence":"additional","affiliation":[{"name":"York Trials Unit, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Oxberry","sequence":"additional","affiliation":[{"name":"Calderdale & Huddersfield Foundation Trust, Huddersfield Royal Infirmary , Huddersfield ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Scarborough Hospital , Scarborough ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Hogg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Glasgow Royal Infirmary, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Darlington Memorial Hospital , Darlington ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Allgar","sequence":"additional","affiliation":[{"name":"Hull York Medical School and Department of Health Sciences, University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics & Clinical Trials, Institute of Health & Well-being, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Clark","sequence":"additional","affiliation":[{"name":"Hull York Medical School, Castle Hill Hospital , Cottingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"2026012115084959300_ehf212498-bib-0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-5151(03)00059-8","article-title":"Symptoms experienced in the last six months of life in patients with end-stage heart failure","volume":"2","author":"Nordgren","year":"2003","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2026012115084959300_ehf212498-bib-0002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/thoraxjnl-2016-209908","article-title":"Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups","volume":"72","author":"Currow","year":"2017","journal-title":"Thorax"},{"key":"2026012115084959300_ehf212498-bib-0003","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/jgs.14313","article-title":"Prevalence and outcomes of breathlessness in older adults: a national population study","volume":"64","author":"Smith","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"2026012115084959300_ehf212498-bib-0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12890-017-0396-4","article-title":"Breathlessness and presentation to the emergency department: a survey and clinical record review","volume":"17","author":"Hutchinson","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2026012115084959300_ehf212498-bib-0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006199-199903000-00004","article-title":"Adult emergency visits for chronic cardiorespiratory disease: does dyspnea matter?","volume":"48","author":"Parshall","year":"1999","journal-title":"Nurs Res"},{"key":"2026012115084959300_ehf212498-bib-0006","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-014-0194-2","article-title":"Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial","volume":"12","author":"Farquhar","year":"2014","journal-title":"BMC Med"},{"key":"2026012115084959300_ehf212498-bib-0007","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2016-209868","article-title":"One evidence base; three stories: do opioids relieve chronic breathlessness?","volume":"73","author":"Ekstrom","year":"2018","journal-title":"Thorax"},{"key":"2026012115084959300_ehf212498-bib-0008","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S2213-2600(14)70226-7","article-title":"An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial","volume":"2","author":"Higginson","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026012115084959300_ehf212498-bib-0009","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuroimage.2009.06.015","article-title":"Dyspnea and pain share emotion-related brain network","volume":"48","author":"von Leupoldt","year":"2009","journal-title":"Neuroimage"},{"key":"2026012115084959300_ehf212498-bib-0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neuroimage.2005.10.033","article-title":"High opiate receptor binding potential in the human lateral pain system","volume":"30","author":"Baumgartner","year":"2006","journal-title":"Neuroimage"},{"key":"2026012115084959300_ehf212498-bib-0011","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/15412555.2011.560132","article-title":"Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD","volume":"8","author":"Gifford","year":"2011","journal-title":"COPD"},{"key":"2026012115084959300_ehf212498-bib-0012","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1183\/09031936.00145208","article-title":"Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD","volume":"33","author":"Mahler","year":"2009","journal-title":"Eur Respir J"},{"key":"2026012115084959300_ehf212498-bib-0013","article-title":"Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness","volume":"3","author":"Barnes","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012115084959300_ehf212498-bib-0014","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1388-9842(02)00158-7","article-title":"Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study","volume":"4","author":"Johnson","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026012115084959300_ehf212498-bib-0015","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/eurjhf\/hfr068","article-title":"Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial","volume":"13","author":"Oxberry","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026012115084959300_ehf212498-bib-0016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/jpm.2012.0270","article-title":"Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough","volume":"16","author":"Oxberry","year":"2013","journal-title":"J Palliat Med"},{"key":"2026012115084959300_ehf212498-bib-0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01153-2017","article-title":"Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis","volume":"50","author":"Verberkt","year":"2017","journal-title":"Eur Respir J"},{"key":"2026012115084959300_ehf212498-bib-0018","article-title":"Using opioids to treat dyspnea in advanced COPD: a survey of Canadian clinicians","volume-title":"Chest","author":"Rocker","year":"2008"},{"key":"2026012115084959300_ehf212498-bib-0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"2026012115084959300_ehf212498-bib-0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"2026012115084959300_ehf212498-bib-0021","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/occmed\/kqm162","article-title":"The MRC breathlessness scale","volume":"58","author":"Stenton","year":"2008","journal-title":"Occup Med (Lond)"},{"key":"2026012115084959300_ehf212498-bib-0022","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4037\/ajcc1998.7.3.200","article-title":"Validity of the numeric rating scale as a measure of dyspnea","volume":"7","author":"Gift","year":"1998","journal-title":"Am J Crit Care"},{"key":"2026012115084959300_ehf212498-bib-0023","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"2026012115084959300_ehf212498-bib-0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of pain","volume":"101","author":"Breivik","year":"2008","journal-title":"Br J Anaesth"},{"key":"2026012115084959300_ehf212498-bib-0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"2026012115084959300_ehf212498-bib-0026","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/eurheartj\/ehi259","article-title":"The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure","volume":"26","author":"Ingle","year":"2005","journal-title":"Eur Heart J"},{"key":"2026012115084959300_ehf212498-bib-0027","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjsm.2006.030262","article-title":"The validation of a novel activity monitor in the measurement of posture and motion during everyday activities","volume":"40","author":"Grant","year":"2006","journal-title":"Br J Sports Med"},{"key":"2026012115084959300_ehf212498-bib-0028","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cardfail.2013.08.001","article-title":"Mild cognitive impairment, screening, and patient perceptions in heart failure patients","volume":"19","author":"Gallagher","year":"2013","journal-title":"J Card Fail"},{"key":"2026012115084959300_ehf212498-bib-0029","volume-title":"Nomenclature and criteria for diagnosis of diseases of the heart and great vessels","author":"The Criteria Committee of the New York Heart Association","year":"1994","edition":"6th ed."},{"key":"2026012115084959300_ehf212498-bib-0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-684X-4-7","article-title":"The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]","volume":"4","author":"Abernethy","year":"2005","journal-title":"BMC Palliat Care"},{"key":"2026012115084959300_ehf212498-bib-0031","doi-asserted-by":"crossref","first-page":"A248","DOI":"10.1161\/circoutcomes.6.suppl_1.A248","article-title":"The KCCQ-12: A short version of the Kansas City Cardiomyopathy Questionnaire","volume":"6","author":"Jones","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026012115084959300_ehf212498-bib-0032","volume-title":"Common terminology criteria for adverse events version 4.03. 1-6-2010. US Department of Health and Human Services","author":"National Institute for Health, National Cancer Institute"},{"key":"2026012115084959300_ehf212498-bib-0033","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.clinph.2006.03.011","article-title":"Validation of the Karolinska sleepiness scale against performance and EEG variables","volume":"117","author":"Kaida","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"2026012115084959300_ehf212498-bib-0034","volume-title":"Quality of life and pharmacoeconomics in clinical trials","author":"Kind","year":"1996"},{"key":"2026012115084959300_ehf212498-bib-0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"2026012115084959300_ehf212498-bib-0036","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1001\/jama.285.15.2006","article-title":"CONSORT revised\u2014improving the reporting of randomized trials","volume":"285","author":"Rennie","year":"2001","journal-title":"JAMA"},{"key":"2026012115084959300_ehf212498-bib-0037","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/0269216317746583","article-title":"The impact of therapeutic opioid agonists on driving-related psychomotor skills assessed by a driving simulator or an on-road driving task: a systematic review","volume":"32","author":"Ferreira","year":"2018","journal-title":"Palliat Med"},{"key":"2026012115084959300_ehf212498-bib-0038","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","article-title":"Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea","volume":"327","author":"Abernethy","year":"2003","journal-title":"BMJ"},{"key":"2026012115084959300_ehf212498-bib-0039","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpainsymman.2010.11.021","article-title":"Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study","volume":"42","author":"Currow","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"2026012115084959300_ehf212498-bib-0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/cc13907","article-title":"Brain-kidney crosstalk","volume":"18","author":"Nongnuch","year":"2014","journal-title":"Crit Care"},{"key":"2026012115084959300_ehf212498-bib-0041","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to manage the adverse effects of oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J Clin Oncol"},{"key":"2026012115084959300_ehf212498-bib-0042","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/medicina45060055","article-title":"Barriers to cancer pain management: a review of empirical research","volume":"45","author":"Jacobsen","year":"2009","journal-title":"Medicina (Kaunas)"},{"key":"2026012115084959300_ehf212498-bib-0043","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.00139812","article-title":"Opioids for chronic refractory breathlessness: patient predictors of beneficial response","volume":"42","author":"Johnson","year":"2013","journal-title":"Eur Respir J"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12498","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12498","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/6\/1149\/66136521\/eschf_6_6_1149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/6\/1149\/66136521\/eschf_6_6_1149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:11:00Z","timestamp":1769026260000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/6\/6\/1149\/8403506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,8,6]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12498","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"2019-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}